Annie Luetkemeyer, MD

Professor of Medicine
UCSF

Annie Luetkemeyer, MD is a professor of medicine in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General at the University of California, San Francisco. She is the co-PI for the NIH funded DoxyPEP study, investigating the use of post-exposure doxycycline to reduce bacterial sexually transmitted infections in men who have sex with men & transgender women. Dr. Luetkemeyer is the principal investigator for the UCSF AIDS Clinical Trials Group (ACTG) clinical research site and directs the San Francisco General Hepatitis and HIV Research Center (HHRC).

Disclosure: Hologic (Individual(s) Involved: Self): Donation of STD test kits for RCT of DoxyPEP, Other Financial or Material Support; Mayne Pharma (Individual(s) Involved: Self): Donation of doxycycline for RCT, Other Financial or Material Support

Presentation(s):

• Antibiotics as STD Prophylaxis, in Addition to Prep - Reasonable Protection or Unnecessary Use

  Thursday, October 22, 2020
  3:45pm – 5:00pm EDT